PMID- 33679085
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20220421
IS  - 0976-4879 (Print)
IS  - 0975-7406 (Electronic)
IS  - 0975-7406 (Linking)
VI  - 12
IP  - 4
DP  - 2020 Oct-Dec
TI  - Relationship between Stages of Change and Glycemic Control in Patients with Type 
      2 Diabetes Mellitus in a Primary Health-care Setting.
PG  - 400-405
LID - 10.4103/jpbs.JPBS_156_20 [doi]
AB  - INTRODUCTION: Advanced stages of change (SOC) are usually associated with lower 
      glycated hemoglobin (HbA1c) scores in patients with type 2 diabetes mellitus 
      (T2DM). Additionally, these patients' adherence to antidiabetic medications is 
      crucial to achieve controlled HbA1c scores. The purpose of this study was to 
      determine the relationship between SOC and HbA1c as well as between medication 
      adherence and HbA1c in patients with T2DM in a primary health-care setting in 
      Qatar. MATERIALS AND METHODS: A cross-sectional observational study was conducted 
      in patients with T2DM at the noncommunicable diseases clinics at Mesaimeer 
      Healthcare Center and West Bay Health Care Center. Medication adherence was 
      assessed using the Morisky Medication Adherence Scale (MMAS-8), whereas a 
      two-item SOC questionnaire was used to measure the SOC. HbA1c values were 
      obtained from the electronic database at the clinic. Spearman rank correlations 
      were performed, with the significance level set at alpha < 0.05. RESULTS: A total of 
      387 patients were included in the analysis. More than 75% of them reported that 
      they were in the maintenance stage, and 35.4% of them had a controlled diabetes 
      status. There was no significant correlation between SOC and HbA1c or between 
      medication adherence and HbA1c. CONCLUSIONS: There was no relationship between 
      SOC and HbA1c or between medication adherence and HbA1c in patients with T2DM, 
      indicating that in this study, self-reported measures are not associated with the 
      HbA1c scores of patients.
CI  - Copyright: (c) 2020 Journal of Pharmacy and Bioallied Sciences.
FAU - Arafat, Yara
AU  - Arafat Y
AD  - Clinical Pharmacy and Practice Department, College of Pharmacy, QU Health, Qatar 
      University, Doha, Qatar.
FAU - Mohamed Ibrahim, Mohamed Izham
AU  - Mohamed Ibrahim MI
AD  - Clinical Pharmacy and Practice Department, College of Pharmacy, QU Health, Qatar 
      University, Doha, Qatar.
FAU - Awaisu, Ahmed
AU  - Awaisu A
AD  - Clinical Pharmacy and Practice Department, College of Pharmacy, QU Health, Qatar 
      University, Doha, Qatar.
FAU - Owusu, Yaw
AU  - Owusu Y
AD  - Clinical Pharmacy and Practice Department, College of Pharmacy, QU Health, Qatar 
      University, Doha, Qatar.
LA  - eng
PT  - Journal Article
DEP - 20201008
PL  - India
TA  - J Pharm Bioallied Sci
JT  - Journal of pharmacy & bioallied sciences
JID - 101537209
PMC - PMC7909064
OTO - NOTNLM
OT  - Diabetes mellitus
OT  - glycated hemoglobin
OT  - medication adherence
OT  - stages of change
OT  - transtheoretical model
COIS- There are no conflicts of interest.
EDAT- 2021/03/09 06:00
MHDA- 2021/03/09 06:01
PMCR- 2020/10/01
CRDT- 2021/03/08 05:48
PHST- 2020/02/07 00:00 [received]
PHST- 2020/04/12 00:00 [revised]
PHST- 2020/04/22 00:00 [accepted]
PHST- 2021/03/08 05:48 [entrez]
PHST- 2021/03/09 06:00 [pubmed]
PHST- 2021/03/09 06:01 [medline]
PHST- 2020/10/01 00:00 [pmc-release]
AID - JPBS-12-400 [pii]
AID - 10.4103/jpbs.JPBS_156_20 [doi]
PST - ppublish
SO  - J Pharm Bioallied Sci. 2020 Oct-Dec;12(4):400-405. doi: 10.4103/jpbs.JPBS_156_20. 
      Epub 2020 Oct 8.